Global Canine Separation Anxiety Treatment Market To Generate Profitable Opportunities For Manufacturers During Forecast Period : FactMR

As per Fact.MR – a market research and competitive intelligence provider, the global canine anxiety separation treatment market was valued at US$ 21.4 Mn in 2020, and is expected to exhibit a CAGR of around 6% during the forecast period (2021-2031).

 For More Insights Into The Market, Request a Sample of this Report –

Canines, like human beings, experience anxiety issues. Dog anxiety can affect all breeds; however, it might differ from one dog to another. Separation anxiety is commonly observed in dogs who are overly attached to their owners, and it is estimated to affect around 14% of dogs, globally.

Canines suffering from anxiety often exhibit undesirable behavior such improper urinating and defecation, excessive salivation, and destroying furnishing and exit points such as windows and doors. If ignored or left untreated, it can have a long-term impact on the dog’s mental health. Factors such as these will create demand for better treatment options for separation anxiety disorders in dogs. Also, growing adoption of canines and increasing spend on animal health are anticipated to have a positive impact on market growth.

Key Takeaways from Market Study

  • By drug molecule, clomipramine to hold around 50% value share, globally, primarily owing to its higher effectiveness and well-tolerance in controlling separation anxiety as compared to other drugs.
  • Based on anxiety type, aggressive anxiety is leading with 60% market share, owing to growing destructive behavior among canines.
  • Veterinary clinics widely dominate at 36% market share, owing to growing number veterinary practices and significant prevalence of canine anxiety across various region.
  • By region, North America is expected to dominate the global canine separation anxiety market with a value share of 32% through the forecast period. Europe is the second-largest market with a value share of 21%.

Share Your Requirements & Get Customized Reports –

Key Market Segments Covered in Canine Separation Anxiety Treatment Industry Research

  • By Drug Molecule

    • Alprazolam (XanaX) Canine Separation Anxiety Treatment
    • Amitriptyline Canine Separation Anxiety Treatment
    • Buspirone Canine Separation Anxiety Treatment
    • Clomipramine Canine Separation Anxiety Treatment
    • Dexmedetomidine Canine Separation Anxiety Treatment
    • Diazepam (Valium) Canine Separation Anxiety Treatment
    • Fluoxetine Hydrochloride Canine Separation Anxiety Treatment
    • Others
  • By Anxiety Type

    • Aggressive Canine Separation Anxiety Treatment
    • Non-Aggressive Canine Separation Anxiety Treatment
  • By Distribution Channel

    • Canine Separation Anxiety Treatment through Veterinary Hospitals
    • Canine Separation Anxiety Treatment through Veterinary Clinics
    • Canine Separation Anxiety Treatment through Pharmacies & Drug Stores
    • Canine Separation Anxiety Treatment through Online Pharmacies

Access Research Methodology Prepared By Experts –

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Buy Now –

The report covers following Canine Separation Anxiety Treatment Market insights and assessment that are helpful for all participants involved in the Intradermal Injections market:

  • Data on recently introduced regulations and their impact on key industries and on demand in Intradermal Injections
  • Latest industry Analysis on Canine Separation Anxiety Treatment Market, with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of Canine Separation Anxiety Treatment Market and changing consumer preferences in major industries.
  • Changing Intradermal Injections demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of Intradermal Injections major players
  • Canine Separation Anxiety Treatment Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
  • Intradermal Injections demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

For More Insight-

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2023 The Tribune City - Theme by WPEnjoy · Powered by WordPress